V1 sact_drug_detail
6,385,827 rows · 11 columns
| MERGED_DRUG_DETAIL_ID | MERGED_CYCLE_ID | ORG_CODE_OF_DRUG_PROVIDER | ACTUAL_DOSE_PER_ADMINISTRATION | OPCS_DELIVERY_CODE | ADMINISTRATION_ROUTE | ADMINISTRATION_DATE | DRUG_GROUP | MERGED_PATIENT_ID | MERGED_TUMOUR_ID | MERGED_REGIMEN_ID |
|---|---|---|---|---|---|---|---|---|---|---|
| 16686674 | 330034976 | ED617 | 2450 | null | 1 | 2014-03-30 | CETUXIMAB | 330012339 | 330006888 | 330003173 |
| 16686675 | 330034976 | EQ8 | 4 | null | 1 | 2014-04-02 | IFOSFAMIDE | 330012339 | 330006888 | 330003173 |
| 16686676 | 330034976 | EJR | 132 | X721 | 2 | 2014-04-02 | METHOTREXATE | 330012339 | 330006888 | 330003173 |
| 16686677 | 330034976 | EX950 | 1000 | X729 | 2 | 2014-04-02 | OXALIPLATIN | 330012339 | 330006888 | 330003173 |
| 16686678 | 330034976 | EE813 | 4000 | X724 | 1 | 2014-04-02 | STEROID | 330012339 | 330006888 | 330003173 |
| 16686679 | 330034977 | EK1PP | 140 | null | 1 | 2018-12-12 | GEMCITABINE | 330012390 | 330001679 | 330003201 |
| 16686680 | 330034977 | ENW | 4160 | null | 1 | 2018-12-12 | TRASTUZUMAB | 330012390 | 330001679 | 330003201 |
| 16686681 | 330034978 | ELW | 0 | null | 1 | 2014-04-10 | RITUXIMAB | 330012868 | 330011310 | 330003445 |
| 16686682 | 330034979 | ELW | 1150 | null | 1 | 2016-08-30 | NOT CHEMO | 330013092 | 330001811 | 330003532 |
| 16686683 | 330034979 | EC4 | 8 | X724 | 1 | 2016-09-05 | STEROID | 330013092 | 330001811 | 330003532 |
| 16686684 | 330034981 | ETG01 | 1600 | X724 | 1 | 2015-04-03 | ALEMTUZUMAB | 330013185 | 330001827 | 330003578 |
| 16686685 | 330034982 | ETG01 | 155 | null | 1 | 2016-03-09 | MESNA | 330013253 | 330001842 | 330003618 |
| 16686686 | 330034982 | EZ1 | 420 | null | null | 2016-03-16 | TEMOZOLOMIDE | 330013253 | 330001842 | 330003618 |
| 16686687 | 330034986 | EE813 | 150 | X722 | 2 | 2014-03-22 | ETOPOSIDE | 330014334 | 330001915 | 330003814 |
| 16686688 | 330034986 | EUDUU | 8 | null | 2 | 2014-04-01 | MITOXANTRONE | 330014334 | 330001915 | 330003814 |
| 16686689 | 330034987 | EE813 | 500 | X721 | 1 | null | VINCRISTINE | 330014444 | 330001919 | 330003830 |
| 16686690 | 330034987 | EGU08 | 8 | null | 2 | null | RITUXIMAB | 330014444 | 330001919 | 330003830 |
| 16686692 | 330034991 | EOI | 230 | X724 | 2 | null | CISPLATIN | 330014737 | 330007056 | 330003881 |
| 16686693 | 330034991 | EK1PP | 340 | null | 2 | null | NOT CHEMO | 330014737 | 330007056 | 330003881 |
| 16686694 | 330034991 | EGU02 | 20 | X724 | 1 | null | RITUXIMAB | 330014737 | 330007056 | 330003881 |
| 16686695 | 330034992 | EQ8 | 60 | X729 | 2 | 2015-04-07 | METHOTREXATE | 330014753 | 330012668 | 330003885 |
| 16686696 | 330034993 | EUZ | 200 | X721 | 1 | 2013-11-07 | EPIRUBICIN | 330014800 | 330001950 | 330003898 |
| 16686697 | 330034994 | EX950 | 180 | X724 | 1 | 2017-09-12 | NOT CHEMO | 330014960 | 330007069 | 330003932 |
| 16686698 | 330034994 | EE813 | 20.5 | X724 | 1 | 2017-09-12 | CYTARABINE | 330014960 | 330007069 | 330003932 |
| 16686699 | 330034995 | EE101 | null | null | 2 | 2017-10-12 | CYTARABINE | 330015103 | 330001971 | 330003950 |
| 16686700 | 330034995 | ED301 | 70 | X721 | 2 | 2017-10-12 | STEROID | 330015103 | 330001971 | 330003950 |
| 16686701 | 330034997 | EE105 | 86 | null | 1 | 2015-07-03 | FLUDARABINE | 330015474 | 330001991 | 330004005 |
| 16686702 | 330034999 | EEX02 | 320 | null | 1 | 2015-11-15 | CYTARABINE | 330015847 | 330002016 | 330004068 |
| 16686703 | 330034999 | EPH | 450 | X729 | 1 | 2015-11-15 | METHOTREXATE | 330015847 | 330002016 | 330004068 |
| 16686704 | 330034999 | ED301 | 130 | X724 | 1 | 2015-11-15 | CYTARABINE | 330015847 | 330002016 | 330004068 |
| 16686705 | 330034999 | ECL01 | 2450 | null | 2 | 2015-11-15 | CETUXIMAB | 330015847 | 330002016 | 330004068 |
| 16686706 | 330034999 | EOI | 160 | X724 | 2 | 2015-11-15 | CISPLATIN | 330015847 | 330002016 | 330004068 |
| 16686707 | 330034999 | EGU02 | 90 | null | 1 | 2015-11-15 | CETUXIMAB | 330015847 | 330002016 | 330004068 |
| 16686708 | 330035000 | EE101 | 7200 | null | 1 | 2016-04-25 | IFOSFAMIDE | 330015864 | 330002019 | 330004073 |
| 16686709 | 330035002 | EE101 | 2 | X721 | 1 | 2015-12-08 | BEVACIZUMAB | 330015910 | 330002022 | 330004081 |
| 16686710 | 330035002 | EC5 | 12 | null | 1 | 2015-12-09 | VINCRISTINE | 330015910 | 330002022 | 330004081 |
| 16686711 | 330035002 | EJU04 | 200 | null | 1 | 2015-12-16 | CYTARABINE | 330015910 | 330002022 | 330004081 |
| 16686712 | 330035002 | ECL02 | 2450 | X724 | 1 | 2015-12-16 | NOT CHEMO | 330015910 | 330002022 | 330004081 |
| 16686713 | 330035002 | EKY01 | 50 | null | 1 | 2015-12-16 | CYTARABINE | 330015910 | 330002022 | 330004081 |
| 16686714 | 330035003 | EEX02 | 15000 | null | 1 | 2017-05-09 | VINCRISTINE | 330015946 | 330002024 | 330004086 |
| 16686715 | 330035003 | ED301 | 2 | X721 | 1 | 2017-05-09 | CYCLOPHOSPHAMIDE | 330015946 | 330002024 | 330004086 |
| 16686716 | 330035004 | EJS03 | 0 | X729 | 1 | 2014-07-13 | ETOPOSIDE | 330016340 | 330009859 | 330004152 |
| 16686717 | 330035004 | Haqrsvarq | 2450 | null | 1 | 2014-07-14 | IFOSFAMIDE | 330016340 | 330009859 | 330004152 |
| 16686718 | 330035004 | EZ1 | 186.2 | null | 1 | 2014-08-16 | NOT CHEMO | 330016340 | 330009859 | 330004152 |
| 16686719 | 330035004 | ECL02 | 450 | X724 | 1 | 2014-08-16 | CYTARABINE | 330016340 | 330009859 | 330004152 |
| 16686720 | 330035005 | ECL01 | 1300 | X724 | 1 | 2014-03-28 | NOT CHEMO | 330016828 | 330002088 | 330004244 |
| 16686721 | 330035005 | Haqrsvarq | null | X723 | 1 | 2014-04-05 | ETOPOSIDE | 330016828 | 330002088 | 330004244 |
| 16686722 | 330035007 | ECL01 | 38 | X724 | 2 | 2013-08-29 | CYCLOPHOSPHAMIDE | 330017738 | 330007182 | 330004404 |
| 16686723 | 330035007 | EKY01 | 1900 | X724 | 2 | 2013-09-05 | TRASTUZUMAB | 330017738 | 330007182 | 330004404 |
| 16686724 | 330035008 | ECL01 | 660 | null | 2 | 2013-06-29 | STEROID | 330018043 | 330002166 | 330004464 |